Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Jun 01, 2024
Amorphous solid dispersions for nasal delivery - Powder formulation and particle engineering considerations
Read more
Scientific Article
Scientific Article
/ Feb 15, 2024
Drug Design Strategies, Modes of Action, Synthesis and Industrial Challenges Behind Trifluoromethylated New Chemical Entities
Read more
Scientific Article